SAN DIEGO, May 30, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions announced today that the
Company's SpineTRACK Registry submitted successful quality
performance data to the Centers of Medicare & Medicaid Services
(CMS) on behalf of healthcare providers at Southern Oregon
Neurosurgical & Spine Associates (SONSA) for the Merit-based
Incentive Payment System (MIPS). As a result, SONSA providers are
eligible for a positive adjustment of up to seven percent on all
Medicare reimbursements for the 2020 payment year.
As the longest-running outcomes registry currently offered by
any spine company, the SpineTRACK Registry provides comprehensive
and collaborative data collection solutions for individual
healthcare providers and large health systems. This
NuVasive-sponsored quality improvement tool enables healthcare
providers to track spine patient outcomes throughout a patient's
treatment and recovery.
In its second year as a designated Qualified Clinical Data
Registry (QCDR) through CMS, the SpineTRACK Registry can submit
quality data directly to CMS on behalf of MIPS-eligible providers
as required by Medicare's Quality Payment Program (QPP). With
SpineTRACK, providers can collect and report patient-reported
measures, independent of electronic medical records, to meet 45
percent of the MIPS performance score for the 2019 reporting year.
Utilizing the SpineTRACK Registry can help eligible providers and
health systems meet Medicare reporting requirements and qualify for
higher payments while avoiding a negative payment adjustment.
"SpineTRACK is an integral part of our practice, and we are very
pleased with our decision to utilize this platform. The ability to
visually display outcomes for patients has been extremely helpful
when discussing a patient's options for surgery," said Matthew L. Miller, MD, at SONSA in Medford, Oregon. "Additionally, analyzing the
patient-reported data helps me and my colleagues to become better
spine surgeons."
Since launching in 2011, SpineTRACK has more than 14,000
patients with over 20 spinal procedures represented, and the data
collected has supported more than 25 peer-reviewed papers.
"The SpineTRACK Registry is a differentiated platform that meets
CMS quality reporting requirements solely through patient-reported
outcomes, alleviating healthcare providers from additional
administrative requirements seen in more common reporting
measures," said Rebecca Smith,
director of Clinical Affairs at NuVasive. "As the U.S. healthcare
system moves more towards a pay-for-performance model, patient data
like what is being collected in SpineTRACK will be vital for
providers and health systems to continue improving care
delivery."
SpineTRACK Registry website:
https://www.nuvasive.com/resources/spinetrack-registry/
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-spinetrack-registry-successfully-meets-2018-medicare-reporting-requirements-for-merit-based-incentive-payments-system-300858823.html
SOURCE NuVasive, Inc.